Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 282 TWD 0.18% Market Closed
Market Cap: 74.8B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Gross Margin
Lotus Pharmaceutical Co Ltd

54.6%
Current
51%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.6%
=
Gross Profit
9.3B
/
Revenue
16.9B

Gross Margin Across Competitors

Country TW
Market Cap 74.6B TWD
Gross Margin
55%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 761.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 368.4B USD
Gross Margin
69%
Country US
Market Cap 250.9B USD
Gross Margin
77%
Country CH
Market Cap 208.8B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 158.6B GBP
Gross Margin
82%
Country IE
Market Cap 155B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Lotus Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.6%
=
Gross Profit
9.3B
/
Revenue
16.9B
What is the Gross Margin of Lotus Pharmaceutical Co Ltd?

Based on Lotus Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 54.6%.